Cargando…
Schistosomiasis Mansoni: Novel Chemotherapy Using a Cysteine Protease Inhibitor
BACKGROUND: Schistosomiasis is a chronic, debilitating parasitic disease infecting more than 200 million people and is second only to malaria in terms of public health importance. Due to the lack of a vaccine, patient therapy is heavily reliant on chemotherapy with praziquantel as the World Health O...
Autores principales: | Abdulla, Maha-Hamadien, Lim, Kee-Chong, Sajid, Mohammed, McKerrow, James H, Caffrey, Conor R |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1764436/ https://www.ncbi.nlm.nih.gov/pubmed/17214506 http://dx.doi.org/10.1371/journal.pmed.0040014 |
Ejemplares similares
-
Proteomic Identification of IPSE/alpha-1 as a Major Hepatotoxin Secreted by Schistosoma mansoni Eggs
por: Abdulla, Maha-Hamadien, et al.
Publicado: (2011) -
SmCL3, a Gastrodermal Cysteine Protease of the Human Blood Fluke Schistosoma mansoni
por: Dvořák, Jan, et al.
Publicado: (2009) -
Drug Discovery for Schistosomiasis: Hit and Lead Compounds Identified in a Library of Known Drugs by Medium-Throughput Phenotypic Screening
por: Abdulla, Maha-Hamadien, et al.
Publicado: (2009) -
Update on drug development targeting parasite cysteine proteases
por: McKerrow, James H.
Publicado: (2018) -
Cysteine Protease Inhibitors Cure an Experimental Trypanosoma cruzi Infection
por: Engel, Juan C., et al.
Publicado: (1998)